ヒストンのH3K36変異は,変化したヒストンのメチル化経路を通じてサルコマゲネシスを促進する
Chao Lu1, Siddhant U Jain2, Dominik Hoelper2
1Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, NY 10065, USA.
まとめ
ヒストンH3変異 (H3K36M) は細胞の分化を阻害し,メチル化パターンを破壊してサルコマの形成を促します. このメカニズムは小児がんやヒトの無差別性肉腫で観察されています.
科学分野:
- 分子生物学
- 癌 生物学
- エピジェネティクス
背景:
- 小児がんはしばしばヒストンH3の誤った変異を呈する.
- これらのヒストンの変異によって引き起こされる腫瘍学的メカニズムは十分に理解されていません.
研究 の 目的:
- メゼンキマの原始細胞における H3K36M 変異の機能的影響を調査する.
- H3K36Mによる腫瘍形成の基礎となる分子メカニズムと,ヒトの肉腫に対するその関連性を解明する.
主な方法:
- H3K36M変異モデルを用いた in vivo 研究
- H3K36メチルトランスフェラーゼの活性を評価する酵素測定法
- ヒストンメチル化パターン (H3K36me,H3K27me) とポリコンブ抑制複合体1 (PRC1) の分布の分析
- 人間の無差別サルコマのサンプルにおけるH3K36M/I変異の特定
主要な成果:
- H3K36M変異はメゼンキマ原細胞の分化を阻害し,インビボでは未分化サルコマを誘発する.
- H3K36M変異核細胞は,H3K36メチルトランスフェラーゼの枯渇またはH3K36I変異の効果を模倣して,H3K36メチルトランスフェラーゼを阻害する.
- H3K36メチル化が失われると,H3K27メチル化が増加し,PRC1の再配分,分化阻害遺伝子の抑制が減少する.
- 新しいH3.1 K36M/ I変異がヒトの無差別サルコマで確認された.
結論:
- H3K36Mの変異は,メゼンキマの微分化の表遺伝的調節を妨害することによって,サルコマの発症を誘導する.
- ヒストンのメチル化とPRC1の活性が変化した新たな腫瘍発生メカニズムが明らかになった.
- この研究は,ヒトの未分類性肉腫における潜在的な要因として,H3 K36M/ I変異を特定し,臨床前モデルとヒトの疾患を関連付けています.
関連する概念動画
Histone Variants at the Centromere
5.2K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
5.2K
Epigenetic Regulation
4.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
4.1K
Epigenetic Regulation
34.2K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.2K
Histone Modification
17.0K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
17.0K
Histone Modification
4.9K
4.9K
Spreading of Chromatin Modifications
9.9K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
9.9K


